Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|March 24, 2016
Diverse fission yeast genes required for responding to oxidative and metal stress: Comparative analysis of glutathione-related and other defense gene deletionsTomáš Pluskal, Kenichi Sajiki, Joanne Becker, et al.
Blood Reviews|February 28, 2012
Hyperleukocytosis, leukostasis and leukapheresis: practice managementChezi Ganzel, Joanne Becker, Paul D Mintz, et al.
Transfusion|January 19, 2016
Rituximab-refractory thrombotic thrombocytopenic purpura responsive to intravenous but not subcutaneous bortezomibPriyank P Patel, Joanne Becker, Craig Freyer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 2009
Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case reportAnubha Bharthuar, Lori Egloff, Joanne Becker, et al.
Journal of Clinical Apheresis|July 4, 2019
Vascular access practices for therapeutic apheresis: Results of a surveyYvette C Tanhehco, Nicole D Zantek, Mohamed Alsammak, et al.
Transfusion|October 16, 2023
How do I manage a blood product shortage?Richard Gammon, Joanne Becker, Tracy Cameron, et al.
Blood|November 12, 2005
Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidenceMinoo Battiwalla, Theresa Hahn, Marija Radovic, et al.
Transfusion|February 23, 2021
Apheresis physician well-being during the COVID-19 pandemic: Results of a surveyYvette C Tanhehco, Yanhua Li, Nicole D Zantek, et al.
Transplantation and Cellular Therapy|November 27, 2022
Short-Term Storage of Mobilized Peripheral Blood Stem Cells in a Closed System Changes the Microenvironment and May Affect the Quantity of CD34<sup>+</sup> and CD34<sup>+</sup>CD38<sup>-</sup>CD45RA<sup>-</sup>CD90<sup>+</sup> CellsAmro Elshoury, Orla Maguire, Alexis Conway, et al.
Transplantation|December 16, 2004
Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletionTheresa Hahn, Arif Raza Alam, David Lawrence, et al.
Pageof 2